Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
Berkeley Premium Neutraceuticals in Cincinnati has been hit with two class-action lawsuits over its Enzyte “all-natural male enhancement” product. Both allege there is no evidence to support Enzyte’s advertised claim that it increases penis size, and both seek cash back for thousands of customers.
The suits, filed in Ohio and California in March, are the latest in a line of troubles for Berkeley. Until now, the company has promoted Enzyte without any peer-reviewed scientific evidence, a rep confirmed.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in